Literature DB >> 33571492

US referral center experience removing nonpalpable and difficult contraceptive implants with in-office ultrasonography: A case series.

Namrata Mastey1, Melissa C Matulich2, Suji Uhm2, Courtney C Baker2, Juliana Melo2, Melissa J Chen2, Mitchell D Creinin2.   

Abstract

OBJECTIVES: To assess referral center outcomes with removal of difficult or nonpalpable contraceptive implants using high-frequency point-of-care ultrasonography. STUDY
DESIGN: We present a case series examining patients referred to our specialty center from January 2019 through September 2020 for difficult or nonpalpable implant removal.
RESULTS: Of the 54 referrals, 6 had palpable implants and 48 required ultrasonography. We localized 46 (96%) implants in-office, including 13 located subfascially; 2 Implanon implants could not be localized. We successfully completed 50 (96%) of 52 attempted in-office removals, including 12 (92%) subfascial implants.
CONCLUSION: High-frequency point-of-care ultrasonography can effectively localize nonpalpable contraceptive implants leading to successful in-office removal. IMPLICATIONS: Specialists can use high-frequency point-of-care ultrasonography to localize nonpalpable implants without formal radiology scans and skilled technologists, optimizing patient time and convenience. However, the probe is expensive, and providers may need to consider this cost in the context of reimbursement for these highly specialized procedures.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Case series; Contraceptive implant; Etonogestrel; Nexplanon; Nonpalpable; Ultrasonography

Year:  2021        PMID: 33571492     DOI: 10.1016/j.contraception.2021.01.018

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  1 in total

1.  Characteristics of Patients Requiring Surgical Removal of Subdermal Contraceptive Implants: A Case-Control Study.

Authors:  Leila Katabi; Erica Stevens; Mona Ascha; Kavita Arora
Journal:  Open Access J Contracept       Date:  2022-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.